You searched for "technological"

1749 results found

Audiology Australia 2023

Embracing the opportunity to meet in person again, the Audiology Australia 2023 Conference is back with the theme ‘Reset. Reconnect. Reignite’. The conference attracts leaders in audiology and hearing technologies from around Australia and the world who will present on...

Hearing care systems in Europe – can we do more?

52 million Europeans experience hearing loss but many don’t find their way to professional hearing care. Lidia Best looks at strategies to improve the uptake of amplification at a national level [1]. With rising numbers of people experiencing hearing loss,...

Genetics and the newborn hearing screen: the future is now

Eliot Shearer shares the progress being made with newborn hearing screening 60 years on from where it started, and future directions for identifying hearing loss using physiologic, genetic and cCMV screening. Newborn screening had its birth in the early 1960s,...

NHS collaboration and partnership with the pharmaceutical and medical devices industries

Historically the relationship between industry and the NHS has been a cautious one. Both sides have typically worked with only partially disclosed agendas, under a pervading fear of finding themselves on the wrong end of a win-lose negotiation. Things have...

Discovery in the genetics of complex disease: Otitis media

Otitis media (OM), a common disease of childhood, is considered to be a complex trait with multiple genetic and environmental factors expected to contribute to a child’s risk of developing recurrent acute OM (rAOM; ≥3 episodes in 6 months or...

RSM ‘Otology Dragon’s Den’

The Royal Society of Medicine Otology Section recently held an ‘Otology Dragon’s Den’ event. Following on from our interview with Professor Gerry O’Donoghue, RSM Otology Section President, in the run-up to this event, we interviewed Steve Broomfield, Consultant Otologist in...

2014: Are today’s implantable devices better than conventional solutions for patients with conductive or mixed hearing loss?

Patients with conductive or mixed hearing loss become candidates for amplification when reconstructive surgery is not viable. Three common amplification options are conventional acoustic devices, such as behind-the-ear devices (BTEs), (implantable) bone-conduction devices and active middle ear implants. The goal...

A ‘smarter’ way to examine the ear?

Otoscopes and endoscopes, essential tools for ENTs, audiologists, and general practitioners, are on the receiving end of a modern twist thanks to smartphone technology. Aimed at adapting smartphones for otoscopic and endoscopic imaging, these reimagined devices might just change the...

Active middle ear implants and bone-anchored hearing systems

The implantable hearing device market has grown significantly over recent years. But as conventional hearing aids improve and cochlear implant candidacy widens, what is the role for active middle ear implants and bone anchored hearing systems, and how should we...

Does septoplasty improve smell?

This is a study from Barcelona on a very interesting topic: does septoplasty change sense of smell? The theory being that a deviated septum would prevent airflow to the olfactory region and once the anatomical obstruction has been relieved, that...

Audiovestibular findings in children with enlarged vestibular aqueduct

Enlarged vestibular aqueduct is reported to affect up to 15% of the paediatric population with sensorineural hearing loss. Devin McCaslin and Bridget Smith provide an up-to-date overview of the mechanisms and clinical symptoms underlying the condition and share some of...

What to do with incidental findings on FDG PET/CT?

18F-fluoro-deoxy-glucose positron emission tomography/computed tomography (FDG PET/CT) is commonly used in head and neck cancer staging. This investigation frequently identifies incidental findings unrelated to the index head and neck cancer. To assess the nature of these incidental findings, notes of...